{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:46:11Z","timestamp":1782726371833,"version":"3.54.5"},"reference-count":49,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Background: Breast cancer (BC) is a biologically heterogeneous disease, with molecular subtypes differing fundamentally in terms of aggressiveness, metabolic behavior, and therapeutic response. Conventional 18F-FDG PET provides semi-quantitative assessment of glucose-analogue uptake using the standardized uptake value (SUV), whereas dynamic PET with Patlak analysis can estimate kinetic parameters such as the net influx rate constant (Ki) and the volume of distribution (Vd). However, the interpretation of these parameters in breast tissue remains insufficiently defined, and data across BC subtypes are limited. This proof-of-concept study explored the feasibility of deriving preliminary reference ranges for non-pathological breast tissue and describing subtype-specific patterns of kinetic parameters. Methods: Six breast cancer patients affected by Luminal (n = 4) or triple negative BC (TNBC, n = 3) and six control patients underwent dynamic 18F-FDG PET\/CT. Patlak kinetic analysis generated parametric Ki and Vd maps. Lesion-level first-order radiomics features were extracted for each breast lesion. Non-lesional breast volumes (contralateral breast and breast excluding disease) were characterized to derive exploratory physiological reference ranges. Results: In control whole-breast tissue, median values were SUV 0.28 g\/mL, Ki 0.056 mL\/min\/100 mL, and Vd ~9%. Non-lesional breast tissue in BC remained statistically concordant with controls. Lesion analysis suggested a possible metabolic gradient across subtypes: Luminal B with low proliferation activity exhibited lowest Ki (0.34 mL\/min\/100 mL), and highest Vd (~39%); Luminal A showed intermediate Ki (1.93 mL\/min\/100 mL) and Vd (~27%) values; TNBC showed higher Ki (3.02 mL\/min\/100 mL) with a greater proportion of zero-valued Vd voxels. Conclusions: This exploratory study suggests that parametric maps may be feasible for describing physiological breast tissue kinetic ranges and for exploring subtype-associated metabolic differences in BC. The observed Ki and Vd patterns may reflect differences in glucose phosphorylation and tracer distribution across tumor phenotypes, but the biological meaning of Patlak-derived parameters requires further methodological and histopathological validation. Larger prospective studies are needed before these parameters can be considered clinically applicable imaging biomarkers.<\/jats:p>","DOI":"10.3390\/cancers18132107","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T08:45:20Z","timestamp":1782722720000},"page":"2107","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Subtype-Specific Metabolic Patterns in Staging Breast Cancer: Insights from Conventional and Parametric PET Radiomics"],"prefix":"10.3390","volume":"18","author":[{"given":"Sara","family":"Calzolai Lettieri","sequence":"first","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelena","family":"Jandric","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidija","family":"Antunovic","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Rodari","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Criscitiello","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"},{"name":"Breast Medical Oncology Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5955-9488","authenticated-orcid":false,"given":"Laura","family":"Evangelista","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"},{"name":"Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5534-0630","authenticated-orcid":false,"given":"Alessia","family":"Artesani","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, Pieve Emanuele, 20072 Milan, Italy"},{"name":"Nuclear Medicine Unit, IRCCS Humanitas Research Hospital, Via Manzoni 56, Rozzano, 20089 Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"103806","DOI":"10.1016\/j.breast.2024.103806","article-title":"Role of [18F]FDG PET\/CT in patients with invasive breast carcinoma of no special type: Literature review and comparison between guidelines","volume":"78","author":"Groheux","year":"2024","journal-title":"Breast"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s40336-021-00426-z","article-title":"Breast cancer: Initial workup and staging with FDG PET\/CT","volume":"9","author":"Groheux","year":"2021","journal-title":"Clin. Transl. Imaging"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2000.18.20.3495","article-title":"Breast Imaging with Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations","volume":"18","author":"Avril","year":"2000","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1148\/radiol.12110853","article-title":"Performance of FDG PET\/CT in the Clinical Management of Breast Cancer","volume":"266","author":"Groheux","year":"2013","journal-title":"Radiology"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Caracciolo, M., Castello, A., Urso, L., Borgia, F., Marzola, M.C., Uccelli, L., Cittanti, C., Bartolomei, M., Castellani, M., and Lopci, E. (2023). Comparison of MRI vs. [18F]FDG PET\/CT for Treatment Response Evaluation of Primary Breast Cancer after Neoadjuvant Chemotherapy: Literature Review and Future Perspectives. J. Clin. Med., 12.","DOI":"10.3390\/jcm12165355"},{"key":"ref_6","first-page":"333","article-title":"Molecular imaging in oncology: Current impact and future directions","volume":"72","author":"Rowe","year":"2022","journal-title":"CA A Cancer J. Clin."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gelardi, F., Tiberio, P., Torrisi, R., Zanca, R., Rodari, M., Zambelli, A., Santoro, A., Fernandes, B., Sagona, A., and Errico, V. (2025). Using [18F]FDG PET\/CT to Identify Optimal Responders to Neoadjuvant Therapy in Breast Cancer\u2014Results from a Prospective Patient Cohort. Cancers, 17.","DOI":"10.3390\/cancers17132133"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e26745","DOI":"10.1097\/MD.0000000000026745","article-title":"Prognostic value of SUVmax in breast cancer and comparative analyses of molecular subtypes: A systematic review and meta-analysis","volume":"100","author":"Jung","year":"2021","journal-title":"Medicine"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9844","DOI":"10.1038\/s41598-023-36958-9","article-title":"Correlation between standardized uptake value of 18F-FDG PET\/CT and conductivity with pathologic prognostic factors in breast cancer","volume":"13","author":"Shin","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_10","first-page":"27","article-title":"Are Changes in PET\/CT SUVmax Associated with Pathologic Complete Response in Breast Cancer Patients Receiving Neoadjuvant Therapy?","volume":"59","author":"Dursun","year":"2026","journal-title":"Acta Haematol. Oncol. Turc."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1148\/radiol.2015141638","article-title":"Early Metabolic Response to Neoadjuvant Treatment: FDG PET\/CT Criteria according to Breast Cancer Subtype","volume":"277","author":"Groheux","year":"2015","journal-title":"Radiology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0140-6736(24)00054-0","article-title":"3-year invasive disease-free survival with chemotherapy de-escalation using an 18F-FDG-PET-based, pathological complete response-adapted strategy in HER2-positive early breast cancer (PHERGain): A randomised, open-label, phase 2 trial","volume":"403","author":"Colleoni","year":"2024","journal-title":"Lancet"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2967\/jnumed.115.163907","article-title":"18F-FDG PET\/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen","volume":"57","author":"Groheux","year":"2016","journal-title":"J. Nucl. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.2967\/jnumed.108.057182","article-title":"Standards for PET Image Acquisition and Quantitative Data Analysis","volume":"50","author":"Boellaard","year":"2009","journal-title":"J. Nucl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2214\/AJR.10.4923","article-title":"A Systematic Review of the Factors Affecting Accuracy of SUV Measurements","volume":"195","author":"Adams","year":"2010","journal-title":"Am. J. Roentgenol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1158\/1078-0432.CCR-07-0074","article-title":"Tumor-Specific Positron Emission Tomography Imaging in Patients: [18F] Fluorodeoxyglucose and Beyond","volume":"13","author":"Mankoff","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0969-8051(00)00138-4","article-title":"Pet physiological measurements using constant infusion","volume":"27","author":"Carson","year":"2000","journal-title":"Nucl. Med. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13550-025-01277-9","article-title":"Model selection for dynamic PET compartmental modelling of 18F-FDG uptake using a long axial field-of-view PET scanner with delay and motion correction","volume":"15","author":"Moradi","year":"2025","journal-title":"EJNMMI Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/jcbfm.1983.1","article-title":"Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data","volume":"3","author":"Patlak","year":"1983","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/s41598-021-82217-0","article-title":"Value of Patlak Ki images from 18F-FDG-PET\/CT for evaluation of the relationships between disease activity and clinical events in cardiac sarcoidosis","volume":"11","author":"Nakajo","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s00259-002-0981-4","article-title":"Comparison of SUV and Patlak slope for monitoring of cancer therapy using serial PET scans","volume":"30","author":"Freedman","year":"2003","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"94","DOI":"10.4274\/mirt.galenos.2022.97658","article-title":"Value of Dynamic 18F-FDG PET\/CT in Predicting the Success of Neoadjuvant Chemotherapy in Patients with Locally Advanced Breast Cancer: A Prospective Study","volume":"32","author":"Kupik","year":"2023","journal-title":"Mol. Imaging Radionucl. Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"035030","DOI":"10.1088\/2057-1976\/add73e","article-title":"Development and evaluation of a bayesian optimization FDG population-based input function for implementing parametric imaging in the clinical practice","volume":"11","author":"Artesani","year":"2025","journal-title":"Biomed. Phys. Eng. Express"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s40658-023-00601-3","article-title":"Clinical application of a population-based input function (PBIF) for a shortened dynamic whole-body FDG-PET\/CT protocol in patients with metastatic melanoma treated by immunotherapy","volume":"10","author":"Pavoine","year":"2023","journal-title":"EJNMMI Phys."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Indovina, L., Scolozzi, V., Capotosti, A., Sestini, S., Taralli, S., Cusumano, D., Giancipoli, R.G., Ciasca, G., Cardillo, G., and Calcagni, M.L. (2021). Short 2-[18F]Fluoro-2-Deoxy-D-Glucose PET Dynamic Acquisition Protocol to Evaluate the Influx Rate Constant by Regional Patlak Graphical Analysis in Patients with Non-Small-Cell Lung Cancer. Front. Med., 8.","DOI":"10.3389\/fmed.2021.725387"},{"key":"ref_26","first-page":"193","article-title":"Short-duration dynamic FDG PET imaging: Optimization and clinical application","volume":"80","author":"Samimi","year":"2020","journal-title":"Phys. Med. Eur. J. Med. Phys."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wang, H., Miao, Y., Yu, W., Zhu, G., Wu, T., Zhao, X., Yuan, G., Li, B., and Xu, H. (2022). Improved Clinical Workflow for Whole-Body Patlak Parametric Imaging Using Two Short Dynamic Acquisitions. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.822708"},{"key":"ref_28","first-page":"105010","article-title":"Motion-resolved parametric imaging derived from short dynamic [18F]FDG PET\/CT scans","volume":"135","author":"Artesani","year":"2025","journal-title":"Phys. Med. Eur. J. Med. Phys."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2967\/jnumed.122.265362","article-title":"Fully Automated, Fast Motion Correction of Dynamic Whole-Body and Total-Body PET\/CT Imaging Studies","volume":"64","author":"Sundar","year":"2023","journal-title":"J. Nucl. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Gutschmayer, S., Muzik, O., Chalampalakis, Z., Ferrara, D., Yu, J., Kluge, K., Rausch, I., Boellaard, R., Golla, S.S.V., and Zuehlsdorff, S. (2022). A scale space theory based motion correction approach for dynamic PET brain imaging studies. Front. Phys., 10.","DOI":"10.3389\/fphy.2022.1034783"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Venet, L., Pati, S., Feldman, M.D., Nasrallah, M.P., Yushkevich, P., and Bakas, S. (2021). Accurate and Robust Alignment of Differently Stained Histologic Images Based on Greedy Diffeomorphic Registration. Appl. Sci., 11.","DOI":"10.3390\/app11041892"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s40658-020-00330-x","article-title":"Assessment of population-based input functions for Patlak imaging of whole body dynamic 18F-FDG PET","volume":"7","author":"Naganawa","year":"2020","journal-title":"EJNMMI Phys."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00259-022-05983-7","article-title":"Feasibility of using abbreviated scan protocols with population-based input functions for accurate kinetic modeling of [18F]-FDG datasets from a long axial FOV PET scanner","volume":"50","author":"Sari","year":"2023","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Artesani, A. (2025). pyPatlak: Open-Source Voxel-Wise Patlak Analysis of Dynamic PET Data. medRxiv.","DOI":"10.1101\/2025.09.16.25335861"},{"key":"ref_35","unstructured":"(2025, September 11). alessiaartesani\/PyPatlak: This Python Tool Performs Patlak Analysis on Dynamic PET Data. It Converts DICOM Files to NIfTI, Scales a Population-Based Input Function with Patient-Specific AIF Data, and Generates Voxel-Wise Ki and Vd Maps. Ideal for Quantitative Analysis in Medical Imaging Research. Available online: https:\/\/github.com\/alessiaartesani\/PyPatlak."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e05267","DOI":"10.1016\/j.heliyon.2020.e05267","article-title":"Intensity threshold based solid tumour segmentation method for Positron Emission Tomography (PET) images: A review","volume":"6","author":"Tamal","year":"2020","journal-title":"Heliyon"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s13139-017-0493-6","article-title":"Current Methods to Define Metabolic Tumor Volume in Positron Emission Tomography: Which One is Better?","volume":"52","author":"Im","year":"2018","journal-title":"Nucl. Med. Mol. Imaging"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e230024","DOI":"10.1148\/ryai.230024","article-title":"TotalSegmentator: Robust Segmentation of 104 Anatomic Structures in CT Images","volume":"5","author":"Wasserthal","year":"2023","journal-title":"Radiol. Artif. Intell."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000351193","article-title":"St. Gallen 2013: Brief Preliminary Summary of the Consensus Discussion","volume":"8","author":"Harbeck","year":"2013","journal-title":"Breast Care"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1186\/bcr3679","article-title":"Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes","volume":"16","author":"Maisonneuve","year":"2014","journal-title":"Breast Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1093\/annonc\/mdt303","article-title":"Personalizing the treatment of women with early breast cancer: Highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013","volume":"24","author":"Goldhirsch","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1007\/s00259-021-05265-8","article-title":"Functional 4-D clustering for characterizing intratumor heterogeneity in dynamic imaging: Evaluation in FDG PET as a prognostic biomarker for breast cancer","volume":"48","author":"Chitalia","year":"2021","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s12253-019-00641-0","article-title":"Dynamic FDG-PET\/CT in the Initial Staging of Primary Breast Cancer: Clinicopathological Correlations","volume":"26","author":"Lengyel","year":"2020","journal-title":"Pathol. Oncol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Wang, Y., Yang, Y., Li, J., Cheng, D., Xu, H., and Huang, J. (2025). Dynamic FDG PET\/CT imaging: Quantitative assessment, advantages and application in the diagnosis of malignant solid tumors. Front. Oncol., 15.","DOI":"10.3389\/fonc.2025.1539911"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e2431712","DOI":"10.2214\/AJR.24.31712","article-title":"Whole-Body Multiparametric PET in Clinical Oncology: Current Status, Challenges, and Opportunities","volume":"223","author":"Fraum","year":"2024","journal-title":"Am. J. Roentgenol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1097\/MNM.0000000000001596","article-title":"Role of dynamic and parametric whole-body FDG PET\/CT imaging in molecular characterization of primary breast cancer: A single institution experience","volume":"43","author":"Sundaraiya","year":"2022","journal-title":"Nucl. Med. Commun."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1158\/1078-0432.CCR-10-2649","article-title":"PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake","volume":"17","author":"Dunnwald","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2967\/jnumed.106.037382","article-title":"Dynamic and Static Approaches to Quantifying 18F-FDG Uptake for Measuring Cancer Response to Therapy, Including the Effect of Granulocyte CSF","volume":"48","author":"Doot","year":"2007","journal-title":"J. Nucl. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13058-023-01722-4","article-title":"Multimodal prediction of neoadjuvant treatment outcome by serial FDG PET and MRI in women with locally advanced breast cancer","volume":"25","author":"Kazerouni","year":"2023","journal-title":"Breast Cancer Res."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/13\/2107\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T09:11:30Z","timestamp":1782724290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/18\/13\/2107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":49,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["cancers18132107"],"URL":"https:\/\/doi.org\/10.3390\/cancers18132107","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]}}}